Mitchell M. Pitlick, M.D.
Allergy & Immunology Physician · Omaha, NE
Mitchell M. Pitlick, M.D. is an allergy & immunology physician with a practice address in Omaha, Nebraska, and NPI 1073044574, issued on Mar 26, 2017. Check the license (Nebraska 35674, as entered in NPPES) on the Nebraska Board of Medicine and Surgery; the Medicare figures below come from public CMS files.
- Name
- Mitchell M. Pitlick
- Credential
- M.D.
- Primary taxonomy
- Allergy & Immunology Physician 207K00000X
- License numbers
- 35674 NE
64170 MN
Self-reported in NPPES; status is on the state search - Practice location
- 2808 South 80TH Avenue, Omaha, NE 68124
- Phone
- (402) 391-1800
- Enumerated
- Mar 26, 2017
- Record last updated
- Mar 28, 2024
- Fax
- (402) 391-1563
- Medicare enrollment
- Enrolled (PECOS I20230803000770); accepts Medicare assignment
- Medical or professional school
- University Of Iowa, Rj & L Carver College Of Medicine, 2017
- Entity
- Type 1 · individual
8 nearest allergy & immunology physician records → All 20 in Nebraska → Look up another NPI →
Verify Mitchell M. Pitlick in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNebraska Board of Medicine and Surgery
Search for license 35674Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
49% fewer Medicare Part D claims than the average allergy & immunology physician in 2024
379 Medicare Part D claims for 78 beneficiaries, against an average of 741 among the 2,899 providers of this specialty who prescribed in Part D. Brand-name drugs were 39% of claims.
Most prescribed
- Ipratropium Bromide58 claims
- Montelukast Sodium46 claims
- Trelegy Ellipta37 claims
- Breo Ellipta32 claims
- Fluticasone Propionate28 claims
- Albuterol Sulfate Hfa19 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $4,054.08
179 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 2,496 providers of this specialty with any payment received $8,321.81 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Allergy Asthma And Immunology Associates PCOmaha, NE
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Mitchell M. Pitlick among 20 allergy & immunology physician records in Nebraska
Mitchell M. Pitlick, M.D. is one of 20 allergy & immunology physician records with a practice address in Nebraska. 90% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2017, is newer than 90% of them.
- NPI issued2017 · 90% of these records are older, 0% newer
- In a Medicare fileYes · 90% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated2017 · median 1999 among the 16 with a school on file
- Record last updated2024 · 75% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207K00000X and a Nebraska practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Allergy & Immunology Physician providers in Nebraska
There are 20 allergy & immunology physician records in Nebraska.
All 20 in Nebraska → Every provider in Omaha → Allergy & Immunology Physician nationwide →
The 8 allergy & immunology physician records with the nearest ZIP codes
- James Friedlander, M.D.Omaha, NE 681241326211889
- Brett Kettelhut, M.D.Omaha, NE 681241538151204
- Roger Kobayashi, M.D.Omaha, NE 681241093707754
- James Tracy, D.O.Omaha, NE 681241801888300
- Gregory Brooks, MDBellevue, NE 681231134178817
- Linda Ford, M.D.Bellevue, NE 681231003886813
- Brian Kelly, M.D.Omaha, NE 681301306089230
- Teodoro Segura, MD, PHDOmaha, NE 681301578644035
Common questions
What is Mitchell M. Pitlick, M.D.'s NPI number?
Mitchell M. Pitlick, M.D.'s National Provider Identifier (NPI) is 1073044574, issued on Mar 26, 2017. An NPI identifies a provider in billing; it is not a license.
Where is Mitchell M. Pitlick, M.D. located?
The NPPES record lists a practice address at 2808 South 80TH Avenue, Omaha, NE, 68124. Phone: (402) 391-1800. Providers update this record themselves, so call before visiting.
How can I verify Mitchell M. Pitlick, M.D.'s license?
NPPES lists Nebraska license number 35674, as entered by the provider. Search the Nebraska Board of Medicine and Surgery at https://www.nebraska.gov/LISSearch/search.cgi. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mitchell M. Pitlick, M.D. prescribe under Medicare Part D?
In 2024, Mitchell M. Pitlick, M.D. had 379 Medicare Part D claims for 78 beneficiaries; the average among allergy & immunology physician prescribers was 741. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.